VTRS

NASD Viatris, Inc.
Oct 4, 2026 · 3:30 AM ET EOD Market Closed

$17.60 ↑ +0.00 (+0.00%) Trading Up from the previous close of $17.60, $0.05 below the day’s high of $17.65

YTD change
+41.37%
vs 20-day SMA
+2.79%
vs 200-day SMA
+15.12%

Price ranges

Previous day
$17.34 $17.65
open $17.53 close $17.60
+$0.07 (+0.40%)
Today
$17.34 $17.65
$17.60
Past week
$17.37 $18.43
from $17.42 now $17.60
+$0.18 (+1.03%)
Past month
$16.15 $18.43
from $17.09 now $17.60
+$0.51 (+2.98%)
This year
$12.19 $18.43
from $12.45 now $17.60
+$5.15 (+41.37%)

Price & Performance

+4.19 (+31.25%) / 6M

$12.75$14.73$16.70$18.68Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 6.7% away from all-time highs of $18.86
  • VTRS is up 41% since the beginning of the year
  • VTRS is up 74% over the past 12 months
  • VTRS is up 3% over the past 1 month
  • 4% of all VTRS investors are betting against VTRS

VTRS reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +73.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.69
Earnings momentum -7.0% Quarterly EPS growth
Quarterly change -7.0%

Valuation

P/E ratio N/A
Enterprise value $32.5B
Beta 0.94

Balance sheet & scale

IncomeN/A
Revenue$14.7B
Cash$1.4B
Debt$13.6M
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $20.2B

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,142.85 -0.61%
JNJ Johnson & Johnson $256.03 -1.02%
ABBV AbbVie, Inc. $262.82 +1.11%
MRK Merck & Co., Inc. $144.30 +0.34%
RHHVF Roche Holding Ltd $428.22 -3.25%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.